GLENMARK PHARMACEUTICALS
Glenmark
Pharmaceuticals Limited is a pharmaceutical company
headquartered in Mumbai, India that
was founded in 1977 by Gracias Saldanha as
a generic drug and active pharmaceutical
ingredient manufacturer;
he named the company after his two sons. The company initially sold its
products in India, Russia, and Africa. The company went public in India in
1999, and used some of the proceeds to build its first research facility.
Saldanha's son Glenn took over as CEO in 2001, having returned to India after
working at PricewaterhouseCoopers. By 2008 Glenmark was the fifth-biggest pharmaceutical company in India.
By 2011 the founder of
the company was one of the richest men in India, and Glenmark had worldwide sales of $778
million, a 37% increase over the last year's sales; the growth was driven by
Glenmark's entry into the US and European generics markets.
In the mid-2010s the
generics industry in general began transitioning to the end of an era of giant patent cliffs in the pharmaceutical
industry; patented drugs with sales of around $28 billion were set to come off
patent in 2018, but in 2019 only about $10 billion in revenue was set to open
for competition, and less the next year. Companies in the industry responded
with consolidation or
trying to generate new, patented drugs.
Glenn Saldanha took the
company down the path of seeking innovation, which was controversial within the
company and with shareholders. The company focused on new drugs and biosimilars in the fields of cancer,
dermatology and respiratory diseases, which it sought to monetize by partnering
with major pharmaceutical companies. In 2016 it had four such drugs in
clinical trials. For the financial year 2016–2017 its sales were around 81
billion INR (ca. $1.25 billion), making it the fourth-biggest Indian
pharmaceutical company.
In May 2019, Yasir Rawjee
was elected as CEO of Glenmark Life Sciences.
Buyers Online
- Customer placed a new order for Duodart 0.5mg/0.4mg, 90 capsules — Made in Germany — Free Delivery
- Customer from ملوي logged in
- Customer from Dublin placed a new order for Fluconazole-Teva 50mg 10 capsules — Made in Hungary — Free Delivery and 1 more product
- Customer from Dublin logged in
- Customer from AL Jaddaf waterfront registered for an account
- Customer from BEN LOMOND logged in
- Customer from BEN LOMOND placed a new order for GROPRINOSIN FORTE 1000MG 30 TABS - MADE IN POLAND- FREE SHIPPING
- Customer from BEN LOMOND registered for an account
- Customer from POUGHKEEPSIE placed a new order for Nazoferon nasal drops 100,000 IU/ml 5 ml — Made in Ukraine — Free Delivery
- Customer from POUGHKEEPSIE updated their account details
- Customer from POUGHKEEPSIE registered for an account
- Customer from Loures registered for an account
- Customer from Holt logged in
- Customer placed a new order for Cerebrolysin solution for injection 215.2 mg/ml, 20 ml (4304 mg) x 5 ampoules — Made in Austria — Free Delivery
- Customer from Englewood logged in
- Customer from Englewood placed a new order for Regulon 0.15mg/0.03mg 63 tablets — Made in Hungary — Free Delivery
- Customer from Englewood logged in
- Customer from Bottenwil placed a new order for BRAVERA CONTROL 96MG/G AEROSOL 8ML — MADE IN POLAND — FREE SHIPPING
- Customer from Bottenwil registered for an account
- Customer from MONTGERON logged in













